UniSa - IRIS Institutional Research Information System

SBARDELLA, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.607
AS - Asia 12.119
EU - Europa 4.247
SA - Sud America 976
Continente sconosciuto - Info sul continente non disponibili 524
AF - Africa 120
OC - Oceania 7
Totale 31.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.321
HK - Hong Kong 7.652
SG - Singapore 1.999
IT - Italia 1.945
CN - Cina 964
BR - Brasile 770
VN - Vietnam 553
UA - Ucraina 487
RU - Federazione Russa 423
DE - Germania 335
TR - Turchia 232
IE - Irlanda 204
FR - Francia 195
KR - Corea 154
FI - Finlandia 149
IN - India 135
CA - Canada 124
SE - Svezia 119
GB - Regno Unito 118
BD - Bangladesh 101
AR - Argentina 76
JP - Giappone 63
MX - Messico 56
PL - Polonia 51
NL - Olanda 49
IQ - Iraq 44
ES - Italia 39
PK - Pakistan 39
ZA - Sudafrica 39
AT - Austria 33
ID - Indonesia 32
EC - Ecuador 30
VE - Venezuela 27
CO - Colombia 25
IL - Israele 24
JM - Giamaica 23
MA - Marocco 20
UZ - Uzbekistan 20
CL - Cile 18
CZ - Repubblica Ceca 16
GR - Grecia 15
SA - Arabia Saudita 14
GT - Guatemala 13
HN - Honduras 13
PH - Filippine 13
CR - Costa Rica 10
DZ - Algeria 10
EU - Europa 10
MY - Malesia 10
TN - Tunisia 10
BO - Bolivia 9
CH - Svizzera 9
JO - Giordania 9
PE - Perù 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
LB - Libano 8
TT - Trinidad e Tobago 8
AL - Albania 7
EG - Egitto 7
KE - Kenya 7
NI - Nicaragua 7
AU - Australia 6
ET - Etiopia 6
HU - Ungheria 6
KZ - Kazakistan 6
LT - Lituania 6
RO - Romania 6
BG - Bulgaria 5
PR - Porto Rico 5
TH - Thailandia 5
NP - Nepal 4
PT - Portogallo 4
RS - Serbia 4
SV - El Salvador 4
BB - Barbados 3
BE - Belgio 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
GH - Ghana 2
LU - Lussemburgo 2
LY - Libia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
AW - Aruba 1
BH - Bahrain 1
Totale 31.056
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.634
Ann Arbor 2.189
Ashburn 1.179
San Jose 1.148
Singapore 999
Chandler 844
Houston 733
Dallas 719
Woodbridge 667
Jacksonville 638
Wilmington 629
Milan 582
Princeton 565
Council Bluffs 365
Beijing 260
Salerno 252
Dublin 199
Izmir 194
Rome 174
The Dalles 163
Dong Ket 161
Lauterbourg 142
São Paulo 137
Nanjing 136
New York 134
Ho Chi Minh City 131
Santa Clara 127
Boardman 122
Andover 120
Munich 106
Los Angeles 94
Hanoi 91
Pellezzano 82
Memphis 77
Moscow 63
Figino 61
Tokyo 60
Mestre 59
Columbus 57
Fairfield 53
Naples 51
Phoenix 50
Chicago 45
Brooklyn 44
Shenyang 39
Dearborn 37
Warsaw 37
Atlanta 35
Hebei 35
Toronto 34
Frankfurt am Main 33
Montreal 33
Changsha 32
Denver 32
Orem 32
Turku 32
Fisciano 31
Norwalk 27
Seoul 27
Washington 27
Jiaxing 26
Nuremberg 26
Turin 26
Boston 25
Nanchang 25
Philadelphia 25
Redwood City 25
Basingstoke 24
Nocera Superiore 24
Pune 23
Rio de Janeiro 23
Düsseldorf 22
Da Nang 21
Falls Church 21
Johannesburg 21
San Francisco 21
Tianjin 21
Vienna 21
Belo Horizonte 20
Mexico City 20
Amsterdam 19
Bologna 19
Guangzhou 19
Jakarta 19
San Diego 19
Chennai 18
Charlotte 17
Tashkent 17
Baghdad 16
Buffalo 16
Seattle 16
Brasília 15
Ankara 14
Helsinki 14
London 14
Athens 13
Catania 13
Florence 13
Haiphong 13
Hải Dương 13
Totale 23.636
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of new selective arginine methyltransferases (PRMTs) Inhibitors 1.288
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 902
Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1 794
ChemInform Abstract: Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors 698
Prodrug Approach to Exploit (S) Alanine as Arginine Mimic Moiety in the Development of Protein Arginine Methyltransferase 4 Inhibitors 543
Synthesis and biological evaluation of delta2-isoxazoline derivatives as DNA methyltransferase 1 (DNMT1) inhibitors 510
Combined HAT/EZH2 modulation leads to cancer-selective cell death 474
Successes and challenges in the development of BD1-selective BET inhibitors: a patent review 451
Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971 391
Modulation of the Activity of Histone Acetyltransferases by Long Chain Alkylidene-malonates (LoCAMs) 384
A new facile and expeditious synthesis of N-hydroxy-N'-phenyloctanediamide, a potent inducer of terminal cytodifferentiation 363
3-(1H-Pyrrol-2- and -3-yl)-2-oxazolidinones as Novel Monoamine Oxidase Type A Inhibitors 346
Identification of novel small-molecule ligands of methyl-lysine binding protein PHF20 341
Identification of small molecules inhibitors of GCN5 histone acetyltransferase activity. 336
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 282
FROM GARCINOL TO BARBITURIC ACID DERIVATIVES: DEVELOPMENT OF NEW AND SELECTIVE P300 INHIBITORS. 282
Developing Spindlin1 small-molecule inhibitors by using protein microarrays 281
Identification of Structural Features of 2-Alkylidene-1,3-Dicarbonyl Derivatives that Induce Inhibition and/or Activation of Histone Acetyltransferases KAT3B/p300 and KAT2B/PCAF 277
A novel cell-permeable, selective and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach 268
3-(1H-Pyrrol-1-yl)-2-oxazolidinones as Reversible, Highly Potent, and Selective Inhibitors of Monoamine Oxidase Type A 255
3,4-Dihydro-2-alkoxy-6-benzyl-oxopyrimidines [DABOs]: Development of a potent class of non-nucleoside reverse transcriptase inhibitors 246
ChemInform Abstract: A Practical, Green, and Selective Approach Toward the Synthesis of Pharmacologically Important Quinone-Containing Heterocyclic Systems Using Alumina-Catalyzed Michael Addition Reaction 244
Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS 242
A continuous-flow synthesis of 1,4-benzodiazepin-5-ones, privileged scaffolds for drug discovery 238
Arginine demethylation of G3BP1 promotes stress granule assembly 231
CARM1 modulators affect epigenome of stem cells and change morphology of nucleoli 225
Preparation of oxo-​pyrimidine compounds for use in pharmaceutical compositions for the treatment of retroviral infection, particularly HIV infection 219
Agenti antimicotici, antimicobatterici e antiprotozoari 218
A regioselective approach toward the synthesis of pharmacologically important quinone-containing heterocyclic systems 214
Identification of Small-Molecule Enhancers of Arginine Methylation Catalyzed by Coactivator-Associated Arginine Methyltransferase 1 213
Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus type 1. 212
In Quest of Chemical Probes for DNA Methylation Reader Proteins: Nucleoside and Dimer Analogues of 5‐Methylcytosine Interact with MBD2 212
Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans 207
Chimica farmaceutica 206
The identification of a novel natural activator of p300 Histone acetyltranferase provides new insights into the modulation mechanism of this enzyme 205
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL G9A INHIBITORS FROM A SCAFFOLD HOPPING APPROACH 203
Use of Microscale Thermophoresis (MST) for Studying binding interactions of PRSet-7/SETD8 with small molecule specific inhibitors EPI-9 and EPI-23. 202
A practical, green and selective approach toward the synthesis of pharmacologically important quinone-containing heterocyclic systems using alumina-catalyzed Michael addition reaction. 200
Small-Molecule Inhibitors of Histone Acetyltransferase Activity: Identification and Biological Properties 196
Design, Synthesis and Biological Evaluation of Carboxy Analogues of Arginine Methyltransferase Inhibitor 1 (AMI-1) 196
Design, synthesis and biological evaluation of novel G9a inhibitors with improved brain permeability from a scaffold hopping approach 193
Design, synthesis and biological evaluation of pyrrole derivatives as coactivator associated arginine methyltransferase 1 (CARM1) inhibitors 193
Biomolecular and biophysical approaches to interrogate p300: a platform for drug discovery. 187
Inside Cover: Identification of Structural Features of 2-Alkylidene-1,3-Dicarbonyl Derivatives that Induce Inhibition and/or Activation of Histone Acetyltransferases KAT3B/p300 and KAT2B/PCAF (ChemMedChem 1/2015) 184
Design, synthesis and in vitro evaluation of bivalent chemical probes for bromo and extra-terminal domain (BET) proteins 183
Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1. 182
Discovery of a novel chemotype of histone lysine methyltransferase EHMT1/2 (GLP/G9a) inhibitors: rational design, synthesis, biological evaluation and co-crystal structure 179
Sympathy for the methyl: a library-on-library screening approach to identify small-molecule ligands of methyl-lysine reader proteins 175
Discovery of benzo[d]imidazole-6-sulfonamides as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain 174
Preparation of 6-​benzyl-​4-​oxopyrimidines as antiviral agents 173
Highly efficient synthesis and chemical separation of 5-amino- and 7-amino-4-hydroxy-2-naphthoic acids 172
A TR-FRET-Based Functional Assay for Screening Activators of CARM1 171
ChemInform Abstract: A Continuous-Flow Synthesis of 1,4-Benzodiazepin-5-ones, Privileged Scaffolds for Drug Discovery 171
Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors 171
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 171
Developing Type II F508del-CFTR correctors with a protective effect against respiratory viruses 169
Straightforward, Metal-free, and Stereoselective Synthesis of 9-Oxo- and 10-Hydroxy-2(E)-decenoic acids, Important Components of Honeybee (Apis mellifera) secretions 169
ChemInform Abstract: Chemical Biology of Histone Acetyltransferase Natural Compounds Modulators 169
Structure–Activity Relationship Refinement and Further Assessment of 4-phenylquinazoline-2-carboxamide Translocator Protein (TSPO) Ligands as Antiproliferative Agents in Human Glioblastoma Tumors. 167
Synthesis of 2-Alkylthio-6-benzyl-3,4-dihydro-4-oxopyrimidines (DABOs) as Potent and Selective HIV-1 Inhibitors 167
N-[4-(1,1'-biphenylyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines, a new class of synthetic antituberculosis agents active against Mycobacterium avium. 166
3-(1H-Pyrrol-2-yl)-2-oxazolidinones as Novel Monoamine Oxidase Type A Inhibitors 166
Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors 163
Regulation of USP37 Expression by REST-associated G9a-dependent Histone Methylation 162
Expanding the quinazoline ring to 3H-benzo[e][1,4]diazepine: development of new and selective G9a inhibitors 162
Preparation of substituted 6-​benzyl-​4-​oxopyrimidines for prevention and treatment of HIV infection 161
5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4( 3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives. 160
Identification of new KDM4 inhibitors through a HTS and hit refinement strategy 159
Chemioterapici antiprotozoari 159
Chemical biology of Histone acetyltransferase natural compounds modulators. 158
3-(4-Aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a New Class of Synthetic Histone Deacetylase Inhibitors 158
5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones, a New Series of Potent, Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors Belonging to the DABO family 157
Identification of new inhibitors of PRMTs by a multi-substrate-adduct approach 154
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells 154
Computer-Aided Design, Synthesis, and Anti-HIV-1 Activity in Vitro of 2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)- ones as Novel Potent Non-Nucleoside Reverse Transcriptase Inhibitors, Also Active Against the Y181C Variant 152
DABOs: A New Class of Non-Nucleoside Reverse Transcriptase Inhibitors 152
P300/CBP Associated Factor Regulates Nitroglycerin-Dependent Arterial Relaxation by N -Lysine Acetylation of Contractile Proteins 151
Discovery of new chemical probes for the MRG15 chromo domain. 151
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase 151
Crystal structure of 3,4-dihydro-6-(3¢-methylbenzyl)-2-[(1-methyl-propyl)thio]-4-oxopyrimidine (S-DABO 618), C16H20N2OS and of 3,4-dihydro-2-[(1-methylpropyl)thio]-6-(2-naphthylmethyl)-4-oxopyrimidine (DATNO 774), C19H20N2OS, two HIV-1 reverse transcriptase inhibitors 150
Nitroquinolones with broad-spectrum antimycobacterial activity in vitro. 150
New 6-nitroquinolones: synthesis and antimicrobial activities 149
A transcriptional coregulator, SPIN-DOC, attenuates the coactivator activity of Spindlin1 148
Identification of new inhibitors of PRMTs by a multi-substrate-adduct approach 148
A “library-on-library” screening approach to identify small-molecule ligands of methyl-lysine reader proteins 147
p300/CBP-Associated Factor Selectively Regulates the Extinction of Conditioned Fear 146
MECHANISMS OF IMMUNE RESISTANCE IN PEDIATRIC POSTERIOR FOSSA TUMORS 146
6-[1-(2,6-Difluorophenyl)ethyl]pyrimidinones Antagonize Cell Proliferation and Induce Cell Differentiation by Inhibiting (a Non Telomeric) Endogenous Reverse Transcriptase 144
ChemInform Abstract: A New Facile and Expeditious Synthesis of N-Hydroxy-N′-phenyloctanediamide, a Potent Inducer of Terminal Cytodifferentiation 144
Modulation of cell differentiation, proliferation, and tumor growth by dihydrobenzyloxopyrimidine non-nucleoside reverse transcriptase inhibitors. 143
A continuous-flow synthesis of 1,4-benzodiazepin-5-ones, privileged scaffolds for drug discovery. 142
From garcinol to barbituric acid derivatives: development of a novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases. 141
Synthesis and Biological Properties of Novel 2-Aminopyrimidin-4(3H)-ones Highly Potent against HIV-1 Mutant Strains 140
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 140
Development of a Non-Radioactive, No-Wash Biochemical Assay for High-Throughput Screening of Small Molecule Modulators of PHF20. 139
Synthesis and biological evaluation of enantiomerically pure pyrrolyl-oxazolidinones as a new class of potent and selective monoamine oxidase type A inhibitors 138
ChemInform Abstract: Nitroquinolones with Broad-Spectrum Antimycobacterial Activity in vitro 138
Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs ? 136
Synthesis and Biochemical Evaluation of Δ2-Isoxazoline Derivatives as DNA Methyltransferase 1 Inhibitors 136
The emerging role of lysine methyltransferase SETD8 in human diseases 136
Totale 23.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.043 0 0 0 8 26 32 20 45 130 142 164 476
2022/20231.823 173 169 56 261 220 355 16 175 285 8 72 33
2023/2024710 62 108 64 30 42 112 38 23 7 27 38 159
2024/20252.495 94 39 45 132 210 268 377 218 423 128 314 247
2025/202615.015 2.142 3.576 3.140 498 940 471 1.221 332 498 858 352 987
2026/20273.021 401 327 924 1.369 0 0 0 0 0 0 0 0
Totale 31.600